STOCK TITAN

Haemonetics Corporation (HAE) Revenue by Year

HAE NYSE

Haemonetics Corporation generated $1.3B in revenue in fiscal year 2026. This represents a decrease of 2.0% from the prior fiscal year. Over the trailing 12 months, Q2 FY2026 through Q1 FY2027, the same line adds up to $1.4B in revenue. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Haemonetics Corporation has filed alongside them.

FY2026 annual
Revenue $1.3B
YoY -2.0%
5Y CAGR +8.9%
10Y CAGR +3.9%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 27, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

HAE Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Revenue$1.4B$1.3B-2.0%$1.4B+4.0%$1.3B+12.0%$1.2B+17.7%$993.2M+14.1%$870.5M-11.9%$988.5M+2.2%$967.6M+7.0%$903.9M+2.0%$886.1M-2.5%$908.8M-0.2%$910.4M-3.0%$938.5M+5.2%$892.0M+22.6%$727.8M

TTM is the trailing twelve months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

HAE Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2710-QQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-Q
Revenue$339.4M+5.6%$346.4M+4.8%$339.0M-2.7%$327.3M-5.3%$321.4M-4.4%$330.6M-3.7%$348.5M+3.7%$345.5M+8.6%$336.2M+8.0%$343.3M+12.8%$336.3M+10.1%$318.2M+7.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Haemonetics Corporation financials

Frequently Asked Questions

What was Haemonetics Corporation's revenue in fiscal year 2026?

Haemonetics Corporation generated $1.3B in revenue in fiscal year 2026.

How fast is Haemonetics Corporation's revenue growing?

Haemonetics Corporation (HAE) revenue fell by 2.0% year over year, from $1.4B to $1.3B in fiscal year 2026.

What is Haemonetics Corporation's revenue over the last twelve months?

Haemonetics Corporation (HAE) reported $1.4B in revenue over the trailing 12 months, Q2 FY2026 through Q1 FY2027, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Haemonetics Corporation (HAE) revenue went from $727.8M in fiscal year 2012 to $1.3B in fiscal year 2026.

Haemonetics Corporation (HAE) reported $339.4M in revenue in Q1 2027. This represents an increase of 5.6% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Haemonetics Corporation (HAE) reported on that line in every period on record.